More than 20 years of hands-on experience in the pharmaceutical industry — market research, market access, business development and strategic analysis for international companies across emerging markets.
Education: Sechenov First Moscow State Medical University (Moscow) and executive education at London Business School. Earlier career includes senior roles at Sandoz (Novartis group) and IMS Health; since 2022, independent market research work contracted through a Georgian individual entrepreneur registration.
Dmitry founded EEHC in Tbilisi to run region-focused research from inside the Caucasus — producing studies for mid-to-large pharmaceutical groups under NDA, with a consistent focus on how markets are regulated, how technologies are assessed, and how medicines are funded.